Pharming Group N.V. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 97.44 million compared to USD 96.76 million a year ago. Net loss was USD 10.89 million compared to net income of USD 19.2 million a year ago.

Basic loss per share from continuing operations was USD 0.017 compared to basic earnings per share from continuing operations of USD 0.029 a year ago. Diluted loss per share from continuing operations was USD 0.017 compared to diluted earnings per share from continuing operations of USD 0.027 a year ago.